Pulmonary hypertension and right heart failure in chronic obstructive pulmonary disease

Proceedings of the American Thoracic Society

Volumn 2, Issue 1, 2005, Pages 20-22

  Naeije, Robert ^a  

^a Erasme Campus ^*  (Belgium)

Author keywords

Chronic obstructive pulmonary disease; Pulmonary hypertension; Right heart failure

Indexed keywords

BOSENTAN; CALCIUM CHANNEL BLOCKING AGENT; ENDOTHELIN RECEPTOR ANTAGONIST; SILDENAFIL; VASODILATOR AGENT;

CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFERENCE PAPER; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; HEART RIGHT VENTRICLE FAILURE; HEMODYNAMICS; HUMAN; IDIOPATHIC DISEASE; INCIDENCE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PREVALENCE; PROGNOSIS; PULMONARY HYPERTENSION; RISK REDUCTION; SMOKING CESSATION; TREATMENT PLANNING;

ANTIHYPERTENSIVE AGENTS; HUMANS; HYPERTENSION, PULMONARY; PIPERAZINES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SULFONAMIDES; VASODILATOR AGENTS; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 17644406055     PISSN: 15463222     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1513/pats.200407-037MS     Document Type: Conference Paper

References (23)

1. Wilkinson M, Langhorn CA, Heath D, Barer GR, Howard P. A pathophysiological study of 10 cases of hypoxic cor pulmonale. Q J Med 1988;66:65-85.
2. Naeije R, Barbera JA. Pulmonary hypertension associated with COPD. Crit Care 2001;5:586-589.
3. Heath D, Williams DR. High-altitude medicine and pathology. London: Butterworths; 1989. pp 102-114.
4. Lejeune P, Mols P, Naeije R, Hallemans R, Mélot C. Acute hemodynamic effects of controlled oxygen therapy in decompensated chronic obstructive pulmonary disease. Crit Care Med 1984;12:1032-1035.
5. Timms RM, Khaja FU, Williams GW, and the Nocturnal Oxygen Therapy Trial Group. Hemodynamic response to oxygen therapy in chronic obstructive pulmonary disease. Ann Intern Med 1985;102:29-36.
6. Naeije R, MacNee W. Pulmonary circulation. In: Calverley P, MacNee W, Pride P, Rennard S, editors. Chronic obstructive pulmonary disease, 2nd edition. London: Arnold Health Sciences; 2003. pp. 228-242.
7. Dinh-Xuan AT, Higenbottam TW, Clelland CA, Pepke-Zaba J, Cremona G, Butt AY, Large SR, Wells FC, Wallwork J. Impairment of endothelium-dependent pulmonary artery relaxation in chronic obstructive lung disease. N Engl J Med 1991;324:1539-1547.
8. Peinado VI, Barberà JA, Ramirez J, Gomez FP, Roca J, Jover L, Gimferrer JM, Rodriguez-Roisin R. Endothelial dysfunction in pulmonary arteries of patients with mild COPD. Am J Physiol 1998;274:L908-L913.
9. Santos S, Peinado VI, Ramirez J, Morales-Blanhir J, Bastos R, Roca J, Rodriguez-Roisin R, Barbera JA. Enhanced expression of vascular endothelial growth factor in pulmonary arteries of smokers and patients with moderate chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003;167:1250-1256.
10. Eddahibi S, Chaouat A, Morrell N, Fadel E, Fuhrman C, Bugnet AS, Dartevelle P, Housset B, Hamon M, Weitzenblum E, et al. Polymorphism of the serotonin transporter gene and pulmonary hypertension in chronic obstructive pulmonary disease. Circulation 2003;108:1839-1844.
11. Scharf SM, Iqbal M, Keller C, Criner G, Lee S, Fessler HE, National Emphysema Treatment Trial (NETT) Group. Hemodynamic characterization of patients with severe emphysema. Am J Respir Crit Care Med 2002;166:314-322.
12. Rubin LJ. Primary pulmonary hypertension. N Engl J Med 1977;336:111-117.
13. Croxton TL, Weinmann GG, Senior RM, Wise RA, Crapo JD, Buist AS. Clinical research in chronic obstructive pulmonary disease: needs and opportunities. Am J Respir Crit Care Med 2003;167:1142-1149.
14. Arcasoy SM, Christie JD, Ferrari VA, Sutton MS, Zisman DA, Blumenthal NP, Pochettino A, Kotloff RM. Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. Am J Respir Crit Care Med 2003;167:735-740.
15. Higham MA, Dawson D, Joshi J, Nihoyannopoulos P, Morrell NW. Utility of echocardiography in assessment of pulmonary hypertension secondary to COPD. Eur Respir J 2001;17:350-355.
16. Marcus JT, Vonk Noordegraaf A, De Vries PM, Van Rossum AC, Roseboom B, Heethaar RM, Postmus PE. MRI evaluation of right ventricular pressure overload in chronic obstructive pulmonary disease. J Magn Reson Imaging 1998;8:999-1005.
17. Weitzenblum E. Chronic cor pulmonale. Heart 2003;89:225-230.
18. Kessler R, Faller M, Weitzenblum E, Chaouat A, Aykut A, Ducolone A, Ehrhart M, Oswald-Mammosser M. "Natural history" of pulmonary hypertension in a series of 131 patients with chronic obstructive lung disease. Am J Respir Crit Care Med 2001;164:219-224.
19. Wasserman K. Diagnosing cardiovascular and lung pathophysiology from exercise gas exchange. Chest 1997;112:1091-1101.
20. Casaburi R. Limitation to exercise tolerance in chronic obstructive pulmonary disease: look to the muscles of ambulation. Am J Respir Crit Care Med 2003;168:409-410.
21. Campbell EJM, Short DS. The cause of oedema in cor pulmonale. Lancet 1960;I:1184-1186.
22. Bauduin SV. Oedema and cor pulmonale revisited. Thorax 1997;52:401-402.
23. Naeije R. Should pulmonary hypertension be treated in chronic obstructive pulmonary disease? In: Weir EK, Archer SL, Reeves JT, editors. The diagnosis and treatment of pulmonary hypertension. New York: Futura Publishing; 1992. pp. 209-239.